A randomized clinical trial of naltrexone and behavioral therapy for problem drinking men who have sex with men.
A randomized clinical trial of naltrexone and behavioral therapy for problem drinking men who have sex with men.
复制标题
DOI:
10.1037/a0028615
复制
发表时间:
2012-10
影响因子:
5.9
通讯作者:
Kranzler, Henry R.
中科院分区:
文献类型:
--
作者:
Morgenstern, Jon;Kuerbis, Alexis N.;Chen, Andrew C.;Kahler, Christopher W.;Bux, Donald A., Jr.;Kranzler, Henry R.
This study tested the comparative effectiveness of Modified Behavioral Self-Control Therapy (MBSCT) and naltrexone (NTX), as well as the added benefit of combining the two, in problem drinking men who have sex with men (MSM) seeking to reduce, but not quit drinking. Method: Participants (N=200) were recruited and urn randomized to one of two medication conditions, NTX or placebo (PBO) and either MSBCT or no behavioral intervention, yielding four conditions: PBO, NTX, MSBCT, and NTX+MSBCT. In addition, all participants received a brief medication compliance intervention. Participants were treated for 12 weeks and assessed one week after treatment completion. Two primary outcomes - sum of standard drinks and number of heavy drinking days - and one secondary outcome - percentage of those drinking in a non-hazardous manner (NoH) - were selected a-priori. Results: There was a significant main effect for MBSCT (all ps < .01), but not NTX on all three outcomes. In addition, the combination of NTX and MBSCT was not more effective than either MSCBT or PBO. There was a significant interaction effect on NoH, such that NTX significantly increased the likelihood (OR = 3.3) of achieving a non-hazardous drinking outcome relative to PBO. In addition, NTX was significantly more effective than PBO on a descriptive outcome: negative consequences of drinking. There was no advantage to adding NTX to MBSCT. In addition, MBSCT showed stronger evidence of efficacy than NTX. At the same time, NTX delivered in the context of a minimal medication compliance intervention was significantly more effective than PBO on an important clinical indicator. Results provide new information to guide the treatment of problem drinking, including in primary care settings.
登录
查看更多内容
影响因子:
2.9
作者:
Kranzler HR;Tennen H;Armeli S;Chan G;Covault J;Arias A;Oncken C
通讯作者:
Oncken C
DOI:
10.15288/jsa.2004.65.774
发表时间:
2004-11-01
期刊:
JOURNAL OF STUDIES ON ALCOHOL
影响因子:
--
作者:
Carey, KB;Carey, MP;Henson, JM
通讯作者:
Henson, JM
DOI:
10.15288/jsa.2000.61.55
发表时间:
2000-01-01
期刊:
JOURNAL OF STUDIES ON ALCOHOL
影响因子:
--
作者:
Babor, TF;Steinberg, K;Del Boca, F
通讯作者:
Del Boca, F
影响因子:
2.9
作者:
Anton, RF;Moak, DH;Woolson, R
通讯作者:
Woolson, R
影响因子:
4.2
作者:
Carroll, KM;Nich, C;Rounsaville, BJ
通讯作者:
Rounsaville, BJ